Company Encyclopedia
View More
name
Bright Eye Hospital Group
301239.SZ
Bright Eye Hospital Group Co., Ltd., a specialized chain medical institution company, engages in the provision of ophthalmic general medical services in China. Its ophthalmology institutions provide diagnosis, treatment, health care, medical optometry, glasses, and other general ophthalmic medical services for patients with ophthalmic diseases in the areas of refractive surgery, cataract, ophthalmology, fundus disease, glaucoma, strabismus and pediatric ophthalmology, tear duct, cornea disease, orbital disease, ocular trauma, medical optometry, and other general ophthalmology diagnosis and treatment items. The company was formerly known as Chengdu Bright Eye Hospital Group Co., Ltd. and changed its name to Bright Eye Hospital Group Co., Ltd.
172.03 B
301239.SZMarket value -Rank by Market Cap -/-

Financial Score

28/12/2025 Update
C
Health Care FacilitiesIndustry
Industry Ranking6/9
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE-4.67%D
    • Profit Margin-3.70%D
    • Gross Margin37.20%B
  • Growth ScoreD
    • Revenue YoY2.00%C
    • Net Profit YoY-202.66%E
    • Total Assets YoY-2.10%D
    • Net Assets YoY-4.90%D
  • Cash ScoreD
    • Cash Flow Margin-2705.49%E
    • OCF YoY2.00%C
  • Operating ScoreB
    • Turnover0.59B
  • Debt ScoreC
    • Gearing Ratio53.52%C

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Bright Eye Hospital Group released its performance for the first three quarters, with a net profit attributable to the parent company of 16.3491 million yuan, an increase of 3.21%

    Bright Eye Hospital Group released its third-quarter report for 2025, with operating revenue for the first three quarters amounting to 2.201 billion yuan, a year-on-year increase of 2.99%; net profit attributable to the parent company was 16.3491 million yuan, a year-on-year increase of 3.21%; net profit excluding non-recurring gains and losses was 24.6698 million yuan, a year-on-year increase of 34.71%; basic earnings per share were 0.11 yuan

    Zhitong·
    SZ
    301239
    -0.45%
    Zhitong·
    SZ
    301239
    -0.45%

    Bright Eye Hospital Group released its performance for the first half of the year, with a net profit attributable to the parent company of 14.6675 million yuan, a decrease of 66.12%

    Bright Eye Hospital Group released its semi-annual report for 2025, with operating revenue of 1.459 billion yuan, a year-on-year increase of 2.74%. The net profit attributable to the parent company was 14.6675 million yuan, a year-on-year decrease of 66.12%; the net profit after deducting non-recurring gains and losses was 20.7809 million yuan, a year-on-year decrease of 54.14%. The basic earnings per share were 0.0985 yuan

    Zhitong·
    SZ
    301239
    -0.45%
    Zhitong·
    SZ
    301239
    -0.45%

    Bright Eye Hospital Group: Using excess raised funds of 22.82 million yuan to establish Chengdu Jinjiang Bright Eye Hospital

    Bright Eye Hospital Group announced that it will use CNY 22.82 million of the raised funds to establish Chengdu Jinjiang Bright Eye Hospital. The total investment for the project is CNY 52.8668 million, with an expected construction period of 11 months, and the investment cost is expected to be recovered in the eighth year. The project will be implemented by the company's wholly-owned subsidiary, located in Jinjiang District, Chengdu

    Zhitong·
    SZ
    301239
    -0.45%
    Zhitong·
    SZ
    301239
    -0.45%

    Bright Eye Hospital Group and others invest to establish a medical device company

    According to the Qichacha APP, recently, Nantong Youci Medical Equipment Co., Ltd. was established, with Cai Aijun as the legal representative. The business scope includes: operation of Class III medical devices; wholesale of pharmaceuticals; retail of pharmaceuticals; sales of Class II medical devices. Qichacha's equity penetration shows that the company is wholly owned by Jiangsu Wenci Ophthalmology Group Co., Ltd., which is jointly held by Nantong Wenbo Medical Management Consulting Partnership and Bright Eye Hospital Group, among others

    Zhitong·
    SZ
    301239
    -0.45%
    Zhitong·
    SZ
    301239
    -0.45%

    Goldman Sachs: The rise of the "silver-haired group" drives growth in high-end out-of-pocket treatment projects, focusing on the main stocks that benefit from this trend

    Goldman Sachs released a research report indicating that between 2024 and 2035, the healthcare spending of individuals aged 50 and above with a net worth exceeding 3 million RMB will significantly increase, with a compound annual growth rate of 14%/19%/9% (baseline/optimistic/pessimistic scenarios). The out-of-pocket medical expenses of this group will drive the growth of high-end treatment projects, particularly high-end dental implants and cataract surgeries. Recommended beneficiary stocks by Goldman Sachs include Aier, IM Motors, and Bright Eye Hospital Group

    Zhitong·
    SZ
    300015
    -0.09%
    SZ
    301239
    -0.45%
    Zhitong·
    SZ
    300015
    -0.09%
    SZ
    301239
    -0.45%
    © 2025 Longbridge｜Disclaimer